Importantly, further experiments will be required to confirm the biological outcome of the direct interaction between ghrelin mimetics and fibrosis-related metalloproteinases also in view of the therapeutic potential of these molecules in DMD and other disorders characterized by excessive fibrosis and pathological tissue remodeling. The gene discussed is GHRL; the disease is Duchenne muscular dystrophy.